Exchange: NASDAQ·Updated 07:18 AM EDT

About INM

About

InMed Pharmaceuticals, Inc. is a pharmaceutical drug development company, which engages in developing small molecule drug candidates that are preferential signaling ligands of the endogenous CB1 and CB2 receptors as well as other receptor targets linked to human disease. The company was founded by Christopher Bogart, Sazzad Hossain, Hyder A. Khoja, and Craig D. Schneider on May 19, 1981 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6

Frequently Asked Questions

What is Market Cap of InMed Pharmaceuticals Inc?
What is the 52-week high for InMed Pharmaceuticals Inc?
What is the 52-week low for InMed Pharmaceuticals Inc?
What is InMed Pharmaceuticals Inc stock price today?
What was InMed Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of InMed Pharmaceuticals Inc?
What is the Price-to-Book ratio of InMed Pharmaceuticals Inc?
What is the 50-day moving average of InMed Pharmaceuticals Inc?
How many employees does InMed Pharmaceuticals Inc have?

Advertisement|Remove ads.